- Home
- FATE vs ORMP Comparison
FATE vs ORMP Comparison
Compare FATE & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FATE | ORMP |
|---|---|---|
| Founded | 2007 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.6M | 134.1M |
| IPO Year | 2013 | 2010 |
Fundamental Metrics
Financial Performance| Metric | FATE | ORMP |
|---|---|---|
| Price | $1.18 | $3.38 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $4.10 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 155.7K |
| Earning Date | 05-29-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.40% |
| EPS Growth | ★ 29.88 | N/A |
| EPS | N/A | ★ 1.26 |
| Revenue | ★ $6,646,000.00 | $1,340,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.05 | N/A |
| P/E Ratio | ★ N/A | $2.68 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.66 | $1.82 |
| 52 Week High | $1.94 | $3.76 |
Technical Indicators
Market Signals| Indicator | FATE | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 40.66 | 50.46 |
| Support Level | $0.96 | $3.22 |
| Resistance Level | $1.35 | $3.76 |
| Average True Range (ATR) | 0.12 | 0.21 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 0.00 | 32.70 |
Price Performance
Historical ComparisonAbout FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.